Santander, Sheena Michelle C.
HRN: 00-44-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2024
CO-AMOXICLAV 625MG (TAB)
03/06/2024
03/12/2024
ORAL
625mg
2 Times A Day
Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes